Blandino G, Inturri R, Lazzara F, Di Rosa M, Malaguarnera L
Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
Diabetes Metab. 2016 Nov;42(5):303-315. doi: 10.1016/j.diabet.2016.04.004. Epub 2016 May 11.
Various functions of the gut are regulated by sophisticated interactions among its functional elements, including the gut microbiota. These microorganisms play a crucial role in gastrointestinal mucosa permeability. They control the fermentation and absorption of dietary polysaccharides to produce short-chain fatty acids, which may explain their importance in the regulation of fat accumulation and the subsequent development of obesity-related diseases, suggesting that they are a crucial mediator of obesity and its consequences. In addition, gut bacteria play a crucial role in the host immune system, modulation of inflammatory processes, extraction of energy from the host diet and alterations of human gene expression. Dietary modulation of the human colonic microbiota has been shown to confer a number of health benefits to the host. Simple therapeutic strategies targeted at attenuating the progression of chronic low-grade inflammation and insulin resistance are urgently required to prevent or slow the development of diabetes in susceptible individuals. The main objective of this review is to address the pathogenic association between gut microbiota and diabetes, and to explore any novel related therapeutic targets. New insights into the role of the gut microbiota in diabetes could lead to the development of integrated strategies using probiotics to prevent and treat these metabolic disorders.
肠道的各种功能由其功能元件(包括肠道微生物群)之间复杂的相互作用来调节。这些微生物在胃肠道黏膜通透性中起着关键作用。它们控制膳食多糖的发酵和吸收以产生短链脂肪酸,这可能解释了它们在调节脂肪堆积及随后肥胖相关疾病发展中的重要性,表明它们是肥胖及其后果的关键介质。此外,肠道细菌在宿主免疫系统、炎症过程的调节、从宿主饮食中提取能量以及人类基因表达的改变中发挥着关键作用。对人类结肠微生物群的饮食调节已被证明能给宿主带来许多健康益处。迫切需要针对减轻慢性低度炎症和胰岛素抵抗进展的简单治疗策略,以预防或减缓易感个体中糖尿病的发展。本综述的主要目的是阐述肠道微生物群与糖尿病之间的致病关联,并探索任何新的相关治疗靶点。对肠道微生物群在糖尿病中作用的新见解可能会促使开发使用益生菌预防和治疗这些代谢紊乱的综合策略。